News Releases

Products

Products
May.10.2019
Certain Media Coverage relating to Opdivo Reported on May 9 (48.0KB)
Products
Feb.26.2019
Launch of Demser® Capsule 250 mg, a Tyrosine Hydroxylase Inhibitor in Japan (83.8KB)
Products
Feb.26.2019
Launch of BRAFTOVI® Capsule 50 mg, a BRAF Inhibitor and MEKTOVI® Tablet 15 mg, a MEK Inhibitor in Japan (175KB)
Products
Feb.15.2017
Launch of PARSABIV® Intravenous Injection for Dialysis (Generic Name: Etelcalcetide Hydrochloride), a Calcimimetic Agent, for Treatment of Secondary Hyperparathyroidism in Patients on Hemodialysis (65.8KB)